| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.793 | 0.004 | 0.793 | Anticonvulsant | 0.498 0.012 CHEMBL1036 0.143 0.138 CHEMBL3527395 0.312 0.037 CHEMBL1269 0.793 0.004 CHEMBL54 | ||
| 0.756 | 0.004 | 0.756 | Dopamine antagonist | 0.597 0.004 CHEMBL1036 0.234 0.016 CHEMBL1269 0.756 0.004 CHEMBL54 | ||
| 0.743 | 0.004 | 0.743 | Dopamine D2 antagonist | 0.585 0.004 CHEMBL1036 0.202 0.017 CHEMBL1269 0.743 0.004 CHEMBL54 | ||
| 0.721 | 0.003 | 0.721 | Dopamine D4 antagonist | 0.507 0.004 CHEMBL1036 0.257 0.009 CHEMBL1269 0.721 0.003 CHEMBL54 | ||
| 0.675 | 0.003 | 0.675 | Dopamine D1 antagonist | 0.561 0.003 CHEMBL1036 0.161 0.014 CHEMBL1269 0.675 0.003 CHEMBL54 | ||
| 0.677 | 0.016 | 0.714 | Analgesic | 0.385 0.091 CHEMBL3527396 0.683 0.015 CHEMBL1036 0.714 0.012 CHEMBL3527395 0.232 0.2 CHEMBL1269 0.677 0.016 CHEMBL54 | CHEMBL3527395 | |
| 0.61 | 0.004 | 0.61 | 5 Hydroxytryptamine 2B antagonist | 0.407 0.008 CHEMBL1036 0.495 0.005 CHEMBL1269 0.61 0.004 CHEMBL54 | ||
| 0.591 | 0.005 | 0.591 | 5 Hydroxytryptamine 2 antagonist | 0.502 0.006 CHEMBL1036 0.479 0.007 CHEMBL1269 0.591 0.005 CHEMBL54 | ||
| 0.549 | 0.004 | 0.549 | 5 Hydroxytryptamine 2C antagonist | 0.314 0.008 CHEMBL1036 0.435 0.005 CHEMBL1269 0.549 0.004 CHEMBL54 | ||
| 0.528 | 0.004 | 0.528 | 5 Hydroxytryptamine 2A antagonist | 0.45 0.005 CHEMBL1036 0.391 0.007 CHEMBL1269 0.528 0.004 CHEMBL54 | ||
| 0.495 | 0.003 | 0.659 | Dopamine uptake inhibitor | 0.659 0.003 CHEMBL1036 0.195 0.006 CHEMBL1269 0.495 0.003 CHEMBL54 | CHEMBL1036 | |
| 0.493 | 0.004 | 0.493 | Histamine H1 receptor antagonist | 0.132 0.029 CHEMBL3527396 0.464 0.004 CHEMBL1036 0.085 0.053 CHEMBL3527395 0.273 0.008 CHEMBL1269 0.493 0.004 CHEMBL54 | ||
| 0.491 | 0.004 | 0.601 | NMDA receptor antagonist | 0.601 0.004 CHEMBL1036 0.107 0.043 CHEMBL1269 0.491 0.004 CHEMBL54 | CHEMBL1036 | |
| 0.489 | 0.004 | 0.489 | Nav1.1 sodium channel blocker | 0.196 0.02 CHEMBL3527396 0.436 0.004 CHEMBL1036 0.154 0.031 CHEMBL3527395 0.149 0.033 CHEMBL1269 0.489 0.004 CHEMBL54 | ||
| 0.499 | 0.015 | 0.599 | HERG channel blocker | 0.149 0.132 CHEMBL3527396 0.599 0.008 CHEMBL1036 0.166 0.114 CHEMBL1269 0.499 0.015 CHEMBL54 | CHEMBL1036 | |
| 0.492 | 0.015 | 0.594 | Potassium channel (Voltage-sensitive) blocker | 0.594 0.008 CHEMBL1036 0.19 0.103 CHEMBL1269 0.492 0.015 CHEMBL54 | CHEMBL1036 | |
| 0.466 | 0.004 | 0.484 | CC chemokine receptor antagonist | 0.069 0.064 CHEMBL3527396 0.484 0.004 CHEMBL1036 0.466 0.004 CHEMBL54 | CHEMBL1036 | |
| 0.464 | 0.009 | 0.464 | 5 Hydroxytryptamine antagonist | 0.394 0.012 CHEMBL1036 0.328 0.016 CHEMBL1269 0.464 0.009 CHEMBL54 | ||
| 0.454 | 0.002 | 0.454 | CC chemokine 1 receptor antagonist | 0.405 0.002 CHEMBL1036 0.03 0.012 CHEMBL1269 0.454 0.002 CHEMBL54 | ||
| 0.453 | 0.005 | 0.453 | Nav1.2 sodium channel blocker | 0.369 0.009 CHEMBL1036 0.205 0.033 CHEMBL1269 0.453 0.005 CHEMBL54 | ||
| 0.449 | 0.004 | 0.449 | Dopamine D3 antagonist | 0.332 0.005 CHEMBL1036 0.14 0.017 CHEMBL1269 0.449 0.004 CHEMBL54 | ||
| 0.446 | 0.005 | 0.446 | Chemokine receptor antagonist | 0.445 0.005 CHEMBL1036 0.446 0.005 CHEMBL54 | ||
| 0.447 | 0.016 | 0.487 | Potassium channel blocker | 0.487 0.012 CHEMBL1036 0.284 0.052 CHEMBL1269 0.447 0.016 CHEMBL54 | CHEMBL1036 | |
| 0.46 | 0.039 | 0.626 | Cholesterol antagonist | 0.607 0.018 CHEMBL3527396 0.568 0.023 CHEMBL1036 0.626 0.015 CHEMBL3527395 0.46 0.039 CHEMBL54 | CHEMBL3527395 | |
| 0.423 | 0.005 | 0.52 | Alpha 1b adrenoreceptor antagonist | 0.52 0.004 CHEMBL1036 0.143 0.023 CHEMBL1269 0.423 0.005 CHEMBL54 | CHEMBL1036 | |
| 0.418 | 0.004 | 0.418 | Nav1.3 sodium channel blocker | 0.376 0.005 CHEMBL1036 0.279 0.011 CHEMBL1269 0.418 0.004 CHEMBL54 | ||
| 0.403 | 0.005 | 0.468 | 5 Hydroxytryptamine 1A antagonist | 0.468 0.005 CHEMBL1036 0.153 0.02 CHEMBL1269 0.403 0.005 CHEMBL54 | CHEMBL1036 | |
| 0.389 | 0.005 | 0.389 | 5 Hydroxytryptamine 7 antagonist | 0.213 0.011 CHEMBL1036 0.223 0.01 CHEMBL1269 0.389 0.005 CHEMBL54 | ||
| 0.418 | 0.037 | 0.608 | Spasmolytic | 0.479 0.026 CHEMBL3527396 0.58 0.015 CHEMBL1036 0.608 0.012 CHEMBL3527395 0.189 0.129 CHEMBL1269 0.418 0.037 CHEMBL54 | CHEMBL3527395 | |
| 0.383 | 0.004 | 0.383 | Nav1.6 sodium channel blocker | 0.281 0.007 CHEMBL1036 0.22 0.014 CHEMBL1269 0.383 0.004 CHEMBL54 | ||
| 0.38 | 0.003 | 0.38 | 5 Hydroxytryptamine 5A antagonist | 0.219 0.005 CHEMBL1036 0.132 0.01 CHEMBL1269 0.38 0.003 CHEMBL54 | ||
| 0.383 | 0.007 | 0.468 | Antipruritic | 0.26 0.022 CHEMBL3527396 0.468 0.005 CHEMBL1036 0.153 0.091 CHEMBL3527395 0.217 0.038 CHEMBL1269 0.383 0.007 CHEMBL54 | CHEMBL1036 | |
| 0.369 | 0.008 | 0.492 | Alpha 1 adrenoreceptor antagonist | 0.492 0.005 CHEMBL1036 0.15 0.029 CHEMBL1269 0.369 0.008 CHEMBL54 | CHEMBL1036 | |
| 0.368 | 0.007 | 0.418 | 5 Hydroxytryptamine 1 antagonist | 0.418 0.006 CHEMBL1036 0.17 0.02 CHEMBL1269 0.368 0.007 CHEMBL54 | CHEMBL1036 | |
| 0.364 | 0.007 | 0.461 | Alpha 1a adrenoreceptor antagonist | 0.461 0.005 CHEMBL1036 0.111 0.032 CHEMBL1269 0.364 0.007 CHEMBL54 | CHEMBL1036 | |
| 0.358 | 0.011 | 0.491 | Alpha adrenoreceptor antagonist | 0.491 0.006 CHEMBL1036 0.182 0.03 CHEMBL1269 0.358 0.011 CHEMBL54 | CHEMBL1036 | |
| 0.345 | 0.005 | 0.373 | Sigma receptor antagonist | 0.373 0.005 CHEMBL1036 0.082 0.02 CHEMBL1269 0.345 0.005 CHEMBL54 | CHEMBL1036 | |
| 0.338 | 0.004 | 0.338 | 5 Hydroxytryptamine 5 antagonist | 0.2 0.005 CHEMBL1036 0.135 0.009 CHEMBL1269 0.338 0.004 CHEMBL54 | ||
| 0.331 | 0.003 | 0.331 | Sphingosine 1-phosphate receptor 2 antagonist | 0.326 0.003 CHEMBL1036 0.156 0.034 CHEMBL1269 0.331 0.003 CHEMBL54 | ||
| 0.348 | 0.026 | 0.358 | 5 Hydroxytryptamine uptake stimulant | 0.237 0.095 CHEMBL1036 0.358 0.023 CHEMBL1269 0.348 0.026 CHEMBL54 | CHEMBL1269 | |
| 0.338 | 0.023 | 0.338 | P-glycoprotein inhibitor | 0.199 0.065 CHEMBL3527396 0.287 0.031 CHEMBL1036 0.218 0.054 CHEMBL3527395 0.153 0.112 CHEMBL1269 0.338 0.023 CHEMBL54 | ||
| 0.32 | 0.008 | 0.32 | Alpha 2b adrenoreceptor antagonist | 0.222 0.019 CHEMBL1036 0.24 0.016 CHEMBL1269 0.32 0.008 CHEMBL54 | ||
| 0.306 | 0.003 | 0.339 | Sigma 2 receptor antagonist | 0.339 0.003 CHEMBL1036 0.035 0.014 CHEMBL1269 0.306 0.003 CHEMBL54 | CHEMBL1036 | |
| 0.308 | 0.005 | 0.443 | Alpha 1d adrenoreceptor antagonist | 0.443 0.004 CHEMBL1036 0.091 0.026 CHEMBL1269 0.308 0.005 CHEMBL54 | CHEMBL1036 | |
| 0.304 | 0.005 | 0.49 | NMDA 2 receptor antagonist | 0.49 0.004 CHEMBL1036 0.088 0.038 CHEMBL1269 0.304 0.005 CHEMBL54 | CHEMBL1036 | |
| 0.371 | 0.077 | 0.551 | Antiobesity | 0.456 0.048 CHEMBL3527396 0.551 0.028 CHEMBL1036 0.299 0.116 CHEMBL3527395 0.21 0.197 CHEMBL1269 0.371 0.077 CHEMBL54 | CHEMBL1036 | |
| 0.295 | 0.005 | 0.295 | Dopamine D4 agonist | 0.148 0.009 CHEMBL1036 0.12 0.011 CHEMBL1269 0.295 0.005 CHEMBL54 | ||
| 0.333 | 0.064 | 0.395 | Apoptosis antagonist | 0.38 0.044 CHEMBL3527396 0.279 0.101 CHEMBL1036 0.395 0.04 CHEMBL3527395 0.333 0.064 CHEMBL54 | CHEMBL3527395 | |
| 0.266 | 0.003 | 0.266 | Sphingosine 1-phosphate receptor 5 antagonist | 0.216 0.006 CHEMBL1036 0.161 0.045 CHEMBL1269 0.266 0.003 CHEMBL54 | ||
| 0.281 | 0.024 | 0.292 | Neurotrophic factor enhancer | 0.189 0.088 CHEMBL3527396 0.195 0.082 CHEMBL1036 0.292 0.02 CHEMBL3527395 0.252 0.037 CHEMBL1269 0.281 0.024 CHEMBL54 | CHEMBL3527395 | |
| 0.298 | 0.044 | 0.341 | Ca(v)3.3 blocker | 0.27 0.073 CHEMBL1036 0.341 0.017 CHEMBL1269 0.298 0.044 CHEMBL54 | CHEMBL1269 | |
| 0.252 | 0.005 | 0.285 | NMDA 2B receptor antagonist | 0.285 0.004 CHEMBL1036 0.068 0.026 CHEMBL1269 0.252 0.005 CHEMBL54 | CHEMBL1036 | |
| 0.25 | 0.005 | 0.496 | Alpha 1 adrenoreceptor agonist | 0.496 0.003 CHEMBL1036 0.08 0.023 CHEMBL1269 0.25 0.005 CHEMBL54 | CHEMBL1036 | |
| 0.254 | 0.019 | 0.254 | Adenylate cyclase inhibitor | 0.106 0.079 CHEMBL3527396 0.197 0.026 CHEMBL1036 0.133 0.057 CHEMBL3527395 0.254 0.019 CHEMBL54 | ||
| 0.246 | 0.018 | 0.246 | Calcium channel blocker | 0.23 0.021 CHEMBL1036 0.149 0.059 CHEMBL1269 0.246 0.018 CHEMBL54 | ||
| 0.23 | 0.004 | 0.23 | CC chemokine 3 receptor antagonist | 0.222 0.004 CHEMBL1036 0.05 0.024 CHEMBL1269 0.23 0.004 CHEMBL54 | ||
| 0.295 | 0.074 | 0.295 | Lipoxygenase inhibitor | 0.229 0.115 CHEMBL1036 0.186 0.156 CHEMBL1269 0.295 0.074 CHEMBL54 | ||
| 0.223 | 0.014 | 0.254 | Alpha 2c adrenoreceptor antagonist | 0.254 0.01 CHEMBL1036 0.127 0.044 CHEMBL1269 0.223 0.014 CHEMBL54 | CHEMBL1036 | |
| 0.226 | 0.017 | 0.226 | Antihistaminic | 0.202 0.02 CHEMBL1036 0.134 0.037 CHEMBL1269 0.226 0.017 CHEMBL54 | ||
| 0.217 | 0.017 | 0.217 | Histamine antagonist | 0.183 0.022 CHEMBL1036 0.127 0.036 CHEMBL1269 0.217 0.017 CHEMBL54 | ||
| 0.201 | 0.005 | 0.291 | Dopamine D5 antagonist | 0.045 0.029 CHEMBL3527396 0.291 0.004 CHEMBL1036 0.077 0.013 CHEMBL1269 0.201 0.005 CHEMBL54 | CHEMBL1036 | |
| 0.199 | 0.011 | 0.349 | 5 Hydroxytryptamine uptake inhibitor | 0.349 0.005 CHEMBL1036 0.056 0.049 CHEMBL3527395 0.113 0.022 CHEMBL1269 0.199 0.011 CHEMBL54 | CHEMBL1036 | |
| 0.198 | 0.017 | 0.198 | Calcium channel (voltage-sensitive) blocker | 0.128 0.048 CHEMBL1036 0.098 0.087 CHEMBL1269 0.198 0.017 CHEMBL54 | ||
| 0.185 | 0.007 | 0.185 | Amidase inhibitor | 0.095 0.027 CHEMBL1036 0.156 0.009 CHEMBL1269 0.185 0.007 CHEMBL54 | ||
| 0.177 | 0.013 | 0.233 | 5 Hydroxytryptamine 1F antagonist | 0.233 0.008 CHEMBL1036 0.108 0.028 CHEMBL1269 0.177 0.013 CHEMBL54 | CHEMBL1036 | |
| 0.233 | 0.073 | 0.233 | Neuropeptide Y2 antagonist | 0.193 0.133 CHEMBL1036 0.233 0.073 CHEMBL54 | ||
| 0.167 | 0.012 | 0.167 | Cannabinoid receptor antagonist | 0.119 0.022 CHEMBL1036 0.064 0.057 CHEMBL1269 0.167 0.012 CHEMBL54 | ||
| 0.164 | 0.008 | 0.164 | Calcium channel L-type blocker | 0.117 0.017 CHEMBL1036 0.073 0.047 CHEMBL1269 0.164 0.008 CHEMBL54 | ||
| 0.181 | 0.028 | 0.359 | Antiadrenergic | 0.359 0.01 CHEMBL1036 0.087 0.064 CHEMBL1269 0.181 0.028 CHEMBL54 | CHEMBL1036 | |
| 0.157 | 0.007 | 0.157 | Cannabinoid CB2 receptor antagonist | 0.118 0.011 CHEMBL1036 0.157 0.007 CHEMBL54 | ||
| 0.171 | 0.025 | 0.237 | 5 Hydroxytryptamine 3A agonist | 0.109 0.066 CHEMBL1036 0.237 0.007 CHEMBL1269 0.171 0.025 CHEMBL54 | CHEMBL1269 | |
| 0.223 | 0.078 | 0.267 | Cyclic AMP phosphodiesterase inhibitor | 0.179 0.112 CHEMBL3527396 0.172 0.12 CHEMBL1036 0.267 0.056 CHEMBL3527395 0.223 0.078 CHEMBL54 | CHEMBL3527395 | |
| 0.159 | 0.014 | 0.159 | Dopamine agonist | 0.138 0.017 CHEMBL1036 0.079 0.038 CHEMBL1269 0.159 0.014 CHEMBL54 | ||
| 0.173 | 0.029 | 0.353 | Adrenaline antagonist | 0.353 0.01 CHEMBL1036 0.083 0.066 CHEMBL1269 0.173 0.029 CHEMBL54 | CHEMBL1036 | |
| 0.191 | 0.047 | 0.349 | Acetylcholine M1 receptor antagonist | 0.349 0.009 CHEMBL1036 0.191 0.047 CHEMBL54 | CHEMBL1036 | |
| 0.15 | 0.007 | 0.15 | Calcium channel T-type blocker | 0.088 0.019 CHEMBL1036 0.055 0.045 CHEMBL1269 0.15 0.007 CHEMBL54 | ||
| 0.167 | 0.029 | 0.211 | Pregnane X receptor agonist | 0.211 0.008 CHEMBL1036 0.143 0.066 CHEMBL1269 0.167 0.029 CHEMBL54 | CHEMBL1036 | |
| 0.138 | 0.002 | 0.138 | GABA uptake inhibitor | 0.107 0.003 CHEMBL1036 0.138 0.002 CHEMBL54 | ||
| 0.175 | 0.04 | 0.175 | Neurotrophic factor | 0.175 0.041 CHEMBL1036 0.122 0.091 CHEMBL3527395 0.175 0.04 CHEMBL54 | ||
| 0.151 | 0.016 | 0.338 | Alpha adrenoreceptor agonist | 0.338 0.004 CHEMBL1036 0.071 0.045 CHEMBL1269 0.151 0.016 CHEMBL54 | CHEMBL1036 | |
| 0.17 | 0.039 | 0.17 | Glutamate receptor antagonist | 0.168 0.04 CHEMBL1036 0.17 0.039 CHEMBL54 | ||
| 0.141 | 0.015 | 0.226 | Lanosterol 14 alpha demethylase inhibitor | 0.226 0.004 CHEMBL1036 0.153 0.01 CHEMBL1269 0.141 0.015 CHEMBL54 | CHEMBL1036 | |
| 0.135 | 0.011 | 0.193 | Adrenaline uptake inhibitor | 0.193 0.006 CHEMBL1036 0.076 0.03 CHEMBL1269 0.135 0.011 CHEMBL54 | CHEMBL1036 | |
| 0.137 | 0.014 | 0.137 | Histamine H2 receptor antagonist | 0.087 0.052 CHEMBL1269 0.137 0.014 CHEMBL54 | ||
| 0.154 | 0.034 | 0.156 | Ca2+-transporting ATPase inhibitor | 0.14 0.074 CHEMBL3527396 0.156 0.03 CHEMBL1036 0.146 0.054 CHEMBL3527395 0.137 0.085 CHEMBL1269 0.154 0.034 CHEMBL54 | CHEMBL1036 | |
| 0.126 | 0.008 | 0.134 | Neurokinin 2 antagonist | 0.134 0.007 CHEMBL1036 0.126 0.008 CHEMBL54 | CHEMBL1036 | |
| 0.292 | 0.174 | 0.404 | 5 Hydroxytryptamine release inhibitor | 0.244 0.237 CHEMBL1036 0.365 0.103 CHEMBL3527395 0.404 0.075 CHEMBL1269 0.292 0.174 CHEMBL54 | CHEMBL1269 | |
| 0.16 | 0.044 | 0.24 | Anesthetic local | 0.24 0.022 CHEMBL1036 0.16 0.044 CHEMBL54 | CHEMBL1036 | |
| 0.182 | 0.066 | 0.182 | Tumour necrosis factor antagonist | 0.176 0.07 CHEMBL1269 0.182 0.066 CHEMBL54 | ||
| 0.139 | 0.025 | 0.139 | Alpha 2a adrenoreceptor antagonist | 0.094 0.039 CHEMBL1036 0.071 0.057 CHEMBL1269 0.139 0.025 CHEMBL54 | ||
| 0.127 | 0.014 | 0.129 | Leukotriene synthesis inhibitor | 0.068 0.046 CHEMBL3527396 0.129 0.014 CHEMBL1036 0.127 0.014 CHEMBL54 | CHEMBL1036 | |
| 0.121 | 0.009 | 0.121 | Melanin-concentrating hormone receptor 1 antagonist | 0.087 0.018 CHEMBL1269 0.121 0.009 CHEMBL54 | ||
| 0.154 | 0.042 | 0.181 | Cholesterol synthesis inhibitor | 0.181 0.032 CHEMBL1036 0.123 0.063 CHEMBL3527395 0.121 0.064 CHEMBL1269 0.154 0.042 CHEMBL54 | CHEMBL1036 | |
| 0.156 | 0.045 | 0.164 | Farnesoid X receptor antagonist | 0.164 0.039 CHEMBL1036 0.156 0.045 CHEMBL54 | CHEMBL1036 | |
| 0.147 | 0.039 | 0.147 | 5-Lipoxygenase inhibitor | 0.118 0.051 CHEMBL1036 0.147 0.039 CHEMBL54 | ||
| 0.119 | 0.013 | 0.147 | Sphingosine 1-phosphate receptor antagonist | 0.147 0.006 CHEMBL1036 0.074 0.059 CHEMBL1269 0.119 0.013 CHEMBL54 | CHEMBL1036 | |
| 0.239 | 0.136 | 0.249 | Vasodilator, peripheral | 0.214 0.16 CHEMBL1036 0.249 0.128 CHEMBL3527395 0.21 0.164 CHEMBL1269 0.239 0.136 CHEMBL54 | CHEMBL3527395 | |
| 0.108 | 0.006 | 0.118 | Nicotinic alpha3beta2 receptor antagonist | 0.118 0.005 CHEMBL1269 0.108 0.006 CHEMBL54 | CHEMBL1269 | |
| 0.106 | 0.006 | 0.106 | Sigma 1 receptor antagonist | 0.103 0.006 CHEMBL1036 0.026 0.019 CHEMBL1269 0.106 0.006 CHEMBL54 | ||
| 0.103 | 0.006 | 0.103 | MDM2 inhibitor | 0.085 0.015 CHEMBL1036 0.073 0.032 CHEMBL1269 0.103 0.006 CHEMBL54 | ||
| 0.247 | 0.151 | 0.344 | Calcium channel activator | 0.344 0.054 CHEMBL1036 0.25 0.147 CHEMBL1269 0.247 0.151 CHEMBL54 | CHEMBL1036 | |
| 0.115 | 0.02 | 0.115 | Estrogen receptor alpha antagonist | 0.106 0.024 CHEMBL1036 0.115 0.02 CHEMBL54 | ||
| 0.1 | 0.006 | 0.106 | Nociceptin (N/OFQ) receptor antagonist | 0.106 0.005 CHEMBL1036 0.1 0.006 CHEMBL54 | CHEMBL1036 | |
| 0.107 | 0.014 | 0.107 | Cannabinoid CB1 receptor antagonist | 0.081 0.026 CHEMBL1036 0.059 0.045 CHEMBL1269 0.107 0.014 CHEMBL54 | ||
| 0.117 | 0.025 | 0.117 | Opioid kappa receptor antagonist | 0.103 0.032 CHEMBL1036 0.117 0.025 CHEMBL54 | ||
| 0.164 | 0.076 | 0.164 | Sigma receptor agonist | 0.135 0.098 CHEMBL1036 0.164 0.076 CHEMBL54 | ||
| 0.123 | 0.039 | 0.123 | Creatine kinase inhibitor | 0.107 0.052 CHEMBL1036 0.115 0.045 CHEMBL1269 0.123 0.039 CHEMBL54 | ||
| 0.137 | 0.053 | 0.243 | Acetylcholine muscarinic antagonist | 0.243 0.016 CHEMBL1036 0.137 0.053 CHEMBL54 | CHEMBL1036 | |
| 0.11 | 0.027 | 0.11 | Analgesic, opioid | 0.109 0.027 CHEMBL1036 0.11 0.027 CHEMBL54 | ||
| 0.119 | 0.037 | 0.119 | Opioid antagonist | 0.08 0.069 CHEMBL3527396 0.107 0.043 CHEMBL1036 0.119 0.037 CHEMBL54 | ||
| 0.086 | 0.004 | 0.086 | Nerve growth factor antagonist | 0.075 0.005 CHEMBL1036 0.041 0.032 CHEMBL1269 0.086 0.004 CHEMBL54 | ||
| 0.097 | 0.016 | 0.115 | Phospholipase D inhibitor | 0.096 0.017 CHEMBL1036 0.115 0.008 CHEMBL1269 0.097 0.016 CHEMBL54 | CHEMBL1269 | |
| 0.089 | 0.01 | 0.091 | CC chemokine 5 receptor antagonist | 0.091 0.01 CHEMBL1036 0.089 0.01 CHEMBL54 | CHEMBL1036 | |
| 0.092 | 0.015 | 0.092 | Potassium channel (Tandem pore domain) blocker | 0.077 0.041 CHEMBL1036 0.076 0.046 CHEMBL1269 0.092 0.015 CHEMBL54 | ||
| 0.107 | 0.033 | 0.2 | Glutamate receptor agonist | 0.2 0.01 CHEMBL1269 0.107 0.033 CHEMBL54 | CHEMBL1269 | |
| 0.085 | 0.011 | 0.085 | Potassium channel Kv1.3 blocker | 0.067 0.017 CHEMBL1036 0.051 0.029 CHEMBL1269 0.085 0.011 CHEMBL54 | ||
| 0.195 | 0.123 | 0.212 | Superoxide dismutase inhibitor | 0.212 0.104 CHEMBL1269 0.195 0.123 CHEMBL54 | CHEMBL1269 | |
| 0.088 | 0.017 | 0.176 | NMDA 2A receptor antagonist | 0.176 0.005 CHEMBL1036 0.088 0.017 CHEMBL54 | CHEMBL1036 | |
| 0.078 | 0.008 | 0.121 | Substance P antagonist | 0.121 0.005 CHEMBL1036 0.078 0.008 CHEMBL54 | CHEMBL1036 | |
| 0.085 | 0.017 | 0.103 | CC chemokine 2 receptor antagonist | 0.103 0.013 CHEMBL1036 0.085 0.017 CHEMBL54 | CHEMBL1036 | |
| 0.088 | 0.021 | 0.257 | Acetylcholine M5 receptor antagonist | 0.257 0.004 CHEMBL1036 0.063 0.038 CHEMBL1269 0.088 0.021 CHEMBL54 | CHEMBL1036 | |
| 0.08 | 0.013 | 0.196 | 5 Hydroxytryptamine 7 agonist | 0.196 0.004 CHEMBL1269 0.08 0.013 CHEMBL54 | CHEMBL1269 | |
| 0.168 | 0.102 | 0.184 | Psychostimulant | 0.181 0.092 CHEMBL1036 0.168 0.101 CHEMBL3527395 0.184 0.09 CHEMBL1269 0.168 0.102 CHEMBL54 | CHEMBL1269 | |
| 0.069 | 0.003 | 0.072 | Ceramide glucosyltransferase inhibitor | 0.043 0.013 CHEMBL3527396 0.072 0.003 CHEMBL1036 0.065 0.004 CHEMBL3527395 0.068 0.004 CHEMBL1269 0.069 0.003 CHEMBL54 | CHEMBL1036 | |
| 0.178 | 0.116 | 0.292 | Antiamyloidogenic | 0.236 0.078 CHEMBL1036 0.212 0.092 CHEMBL3527395 0.292 0.054 CHEMBL1269 0.178 0.116 CHEMBL54 | CHEMBL1269 | |
| 0.113 | 0.051 | 0.151 | Toll-Like receptor 4 antagonist | 0.146 0.023 CHEMBL3527396 0.117 0.047 CHEMBL1036 0.151 0.02 CHEMBL3527395 0.108 0.058 CHEMBL1269 0.113 0.051 CHEMBL54 | CHEMBL3527395 | |
| 0.104 | 0.045 | 0.121 | Alpha 2 adrenoreceptor antagonist | 0.121 0.036 CHEMBL1036 0.085 0.061 CHEMBL1269 0.104 0.045 CHEMBL54 | CHEMBL1036 | |
| 0.093 | 0.034 | 0.108 | Acetylcholine M4 receptor antagonist | 0.108 0.023 CHEMBL1036 0.084 0.042 CHEMBL1269 0.093 0.034 CHEMBL54 | CHEMBL1036 | |
| 0.092 | 0.035 | 0.092 | Opioid mu receptor antagonist | 0.06 0.054 CHEMBL3527396 0.08 0.04 CHEMBL1036 0.092 0.035 CHEMBL54 | ||
| 0.157 | 0.1 | 0.208 | Succinate dehydrogenase inhibitor | 0.208 0.043 CHEMBL1269 0.157 0.1 CHEMBL54 | CHEMBL1269 | |
| 0.07 | 0.014 | 0.125 | NMDA receptor subunit 3A antagonist | 0.125 0.006 CHEMBL1036 0.07 0.014 CHEMBL54 | CHEMBL1036 | |
| 0.081 | 0.028 | 0.081 | Cannabinoid CB1 receptor agonist | 0.062 0.041 CHEMBL1036 0.081 0.028 CHEMBL54 | ||
| 0.091 | 0.039 | 0.166 | Nicotinic alpha4beta2 receptor antagonist | 0.166 0.005 CHEMBL1269 0.091 0.039 CHEMBL54 | CHEMBL1269 | |
| 0.088 | 0.036 | 0.088 | Viral attachment inhibitor | 0.073 0.066 CHEMBL1036 0.088 0.036 CHEMBL54 | ||
| 0.195 | 0.144 | 0.195 | Tyrosine 3 hydroxylase inhibitor | 0.195 0.144 CHEMBL54 | ||
| 0.128 | 0.078 | 0.217 | Interleukin 1 antagonist | 0.217 0.027 CHEMBL1269 0.128 0.078 CHEMBL54 | CHEMBL1269 | |
| 0.077 | 0.027 | 0.116 | NMDA 2C receptor antagonist | 0.116 0.011 CHEMBL1036 0.077 0.027 CHEMBL54 | CHEMBL1036 | |
| 0.067 | 0.022 | 0.093 | Dopamine transporter inhibitor | 0.093 0.013 CHEMBL1036 0.046 0.036 CHEMBL1269 0.067 0.022 CHEMBL54 | CHEMBL1036 | |
| 0.1 | 0.055 | 0.149 | HIV-1 integrase (Overall Integration) inhibitor | 0.149 0.026 CHEMBL1269 0.1 0.055 CHEMBL54 | CHEMBL1269 | |
| 0.095 | 0.051 | 0.106 | Histamine N-methyltransferase inhibitor | 0.106 0.041 CHEMBL1269 0.095 0.051 CHEMBL54 | CHEMBL1269 | |
| 0.086 | 0.043 | 0.091 | Interferon agonist | 0.091 0.037 CHEMBL3527395 0.086 0.043 CHEMBL54 | CHEMBL3527395 | |
| 0.113 | 0.069 | 0.113 | Estrogen antagonist | 0.104 0.088 CHEMBL1036 0.113 0.069 CHEMBL54 | ||
| 0.061 | 0.017 | 0.061 | Adenylate cyclase 1 inhibitor | 0.047 0.03 CHEMBL1036 0.061 0.017 CHEMBL54 | ||
| 0.182 | 0.139 | 0.202 | 5 Hydroxytryptamine release stimulant | 0.176 0.145 CHEMBL1036 0.17 0.152 CHEMBL3527395 0.202 0.119 CHEMBL1269 0.182 0.139 CHEMBL54 | CHEMBL1269 | |
| 0.065 | 0.022 | 0.103 | Neurokinin antagonist | 0.103 0.01 CHEMBL1036 0.065 0.022 CHEMBL54 | CHEMBL1036 | |
| 0.063 | 0.021 | 0.063 | 5 Hydroxytryptamine 4 antagonist | 0.061 0.023 CHEMBL1269 0.063 0.021 CHEMBL54 | ||
| 0.153 | 0.111 | 0.309 | Non-steroidal antiinflammatory agent | 0.194 0.076 CHEMBL3527396 0.186 0.082 CHEMBL1036 0.309 0.026 CHEMBL3527395 0.206 0.066 CHEMBL1269 0.153 0.111 CHEMBL54 | CHEMBL3527395 | |
| 0.196 | 0.155 | 0.196 | Gastrin inhibitor | 0.188 0.167 CHEMBL1269 0.196 0.155 CHEMBL54 | ||
| 0.077 | 0.036 | 0.093 | Acetylcholine M5 receptor agonist | 0.093 0.024 CHEMBL1269 0.077 0.036 CHEMBL54 | CHEMBL1269 | |
| 0.18 | 0.139 | 0.299 | Cardiotonic | 0.299 0.056 CHEMBL1036 0.18 0.139 CHEMBL54 | CHEMBL1036 | |
| 0.05 | 0.011 | 0.05 | Delayed rectifier potassium channel blocker | 0.049 0.012 CHEMBL1269 0.05 0.011 CHEMBL54 | ||
| 0.063 | 0.024 | 0.067 | 5 Hydroxytryptamine 1A agonist | 0.067 0.023 CHEMBL1036 0.049 0.029 CHEMBL1269 0.063 0.024 CHEMBL54 | CHEMBL1036 | |
| 0.151 | 0.113 | 0.164 | Anesthetic general | 0.155 0.109 CHEMBL1036 0.164 0.1 CHEMBL3527395 0.151 0.113 CHEMBL54 | CHEMBL3527395 | |
| 0.058 | 0.02 | 0.058 | Cholesterol esterase inhibitor | 0.044 0.041 CHEMBL1036 0.058 0.02 CHEMBL54 | ||
| 0.096 | 0.058 | 0.146 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.128 0.035 CHEMBL3527396 0.14 0.03 CHEMBL3527395 0.146 0.028 CHEMBL1269 0.096 0.058 CHEMBL54 | CHEMBL1269 | |
| 0.073 | 0.035 | 0.106 | CDC25B inhibitor | 0.106 0.014 CHEMBL1269 0.073 0.035 CHEMBL54 | CHEMBL1269 | |
| 0.148 | 0.111 | 0.149 | Catenin beta inhibitor | 0.149 0.109 CHEMBL1269 0.148 0.111 CHEMBL54 | CHEMBL1269 | |
| 0.106 | 0.07 | 0.172 | Cystathionine beta-synthase inhibitor | 0.172 0.032 CHEMBL1269 0.106 0.07 CHEMBL54 | CHEMBL1269 | |
| 0.084 | 0.05 | 0.084 | CC chemokine 5 receptor agonist | 0.084 0.05 CHEMBL54 | ||
| 0.049 | 0.015 | 0.073 | Heme oxygenase inhibitor | 0.054 0.009 CHEMBL1036 0.073 0.004 CHEMBL1269 0.049 0.015 CHEMBL54 | CHEMBL1269 | |
| 0.041 | 0.009 | 0.126 | Kynurenine 3 monooxygenase inhibitor | 0.126 0.003 CHEMBL1269 0.041 0.009 CHEMBL54 | CHEMBL1269 | |
| 0.115 | 0.083 | 0.241 | Acetylcholinesterase inhibitor | 0.241 0.023 CHEMBL1269 0.115 0.083 CHEMBL54 | CHEMBL1269 | |
| 0.273 | 0.242 | 0.629 | Antiinflammatory | 0.516 0.081 CHEMBL3527396 0.35 0.173 CHEMBL1036 0.629 0.046 CHEMBL3527395 0.273 0.242 CHEMBL54 | CHEMBL3527395 | |
| 0.115 | 0.085 | 0.115 | Cyclooxygenase 1 inhibitor | 0.102 0.097 CHEMBL1269 0.115 0.085 CHEMBL54 | ||
| 0.074 | 0.044 | 0.102 | HIV-1 integrase inhibitor | 0.102 0.024 CHEMBL1269 0.074 0.044 CHEMBL54 | CHEMBL1269 | |
| 0.078 | 0.05 | 0.081 | GABA aminotransferase inhibitor | 0.069 0.063 CHEMBL3527396 0.081 0.045 CHEMBL3527395 0.078 0.05 CHEMBL54 | CHEMBL3527395 | |
| 0.11 | 0.083 | 0.175 | Cholinergic antagonist | 0.175 0.04 CHEMBL1036 0.116 0.078 CHEMBL1269 0.11 0.083 CHEMBL54 | CHEMBL1036 | |
| 0.068 | 0.04 | 0.068 | 5 Hydroxytryptamine 1D antagonist | 0.068 0.04 CHEMBL54 | ||
| 0.156 | 0.131 | 0.335 | Hypolipemic | 0.187 0.104 CHEMBL3527396 0.335 0.039 CHEMBL1036 0.22 0.082 CHEMBL3527395 0.156 0.131 CHEMBL54 | CHEMBL1036 | |
| 0.063 | 0.038 | 0.202 | Acetylcholine M3 receptor antagonist | 0.202 0.007 CHEMBL1036 0.063 0.038 CHEMBL54 | CHEMBL1036 | |
| 0.107 | 0.083 | 0.173 | Acetylcholine antagonist | 0.173 0.039 CHEMBL1036 0.111 0.079 CHEMBL1269 0.107 0.083 CHEMBL54 | CHEMBL1036 | |
| 0.057 | 0.033 | 0.069 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.069 0.022 CHEMBL1269 0.057 0.033 CHEMBL54 | CHEMBL1269 | |
| 0.039 | 0.016 | 0.039 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.039 0.016 CHEMBL54 | ||
| 0.039 | 0.018 | 0.105 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.105 0.004 CHEMBL1269 0.039 0.018 CHEMBL54 | CHEMBL1269 | |
| 0.05 | 0.029 | 0.05 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.05 0.029 CHEMBL54 | ||
| 0.099 | 0.079 | 0.1 | DOPA decarboxylase inhibitor | 0.1 0.076 CHEMBL1269 0.099 0.079 CHEMBL54 | CHEMBL1269 | |
| 0.057 | 0.037 | 0.064 | Leukotriene C antagonist | 0.064 0.021 CHEMBL1036 0.057 0.037 CHEMBL54 | CHEMBL1036 | |
| 0.032 | 0.012 | 0.032 | DNA polymerase III inhibitor | 0.032 0.012 CHEMBL1036 0.032 0.012 CHEMBL54 | ||
| 0.043 | 0.025 | 0.076 | Neurokinin 1 antagonist | 0.076 0.01 CHEMBL1036 0.043 0.025 CHEMBL54 | CHEMBL1036 | |
| 0.037 | 0.022 | 0.088 | Glutamate (mGluR group II) agonist | 0.088 0.008 CHEMBL1269 0.037 0.022 CHEMBL54 | CHEMBL1269 | |
| 0.07 | 0.056 | 0.09 | CDC25A inhibitor | 0.09 0.034 CHEMBL1269 0.07 0.056 CHEMBL54 | CHEMBL1269 | |
| 0.051 | 0.037 | 0.051 | 5 Hydroxytryptamine 1 agonist | 0.043 0.042 CHEMBL1036 0.043 0.042 CHEMBL1269 0.051 0.037 CHEMBL54 | ||
| 0.027 | 0.013 | 0.068 | Prostaglandin EP2 agonist | 0.068 0.004 CHEMBL1036 0.027 0.013 CHEMBL54 | CHEMBL1036 | |
| 0.038 | 0.024 | 0.039 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.039 0.022 CHEMBL1269 0.038 0.024 CHEMBL54 | CHEMBL1269 | |
| 0.028 | 0.015 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.015 CHEMBL1036 0.028 0.015 CHEMBL54 | ||
| 0.033 | 0.022 | 0.086 | Glutamate (mGluR2) agonist | 0.086 0.008 CHEMBL1269 0.033 0.022 CHEMBL54 | CHEMBL1269 | |
| 0.043 | 0.032 | 0.094 | Nicotinic receptor alpha3 subunit antagonist | 0.094 0.01 CHEMBL1269 0.043 0.032 CHEMBL54 | CHEMBL1269 | |
| 0.045 | 0.034 | 0.045 | Glycine transporter 2 inhibitor | 0.045 0.034 CHEMBL54 | ||
| 0.022 | 0.011 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.013 CHEMBL1036 0.022 0.011 CHEMBL54 | ||
| 0.06 | 0.049 | 0.06 | Cannabinoid receptor agonist | 0.06 0.049 CHEMBL54 | ||
| 0.071 | 0.061 | 0.071 | Vanilloid 4 agonist | 0.069 0.068 CHEMBL1036 0.071 0.061 CHEMBL54 | ||
| 0.077 | 0.069 | 0.077 | Ca(v)3.1 blocker | 0.077 0.069 CHEMBL54 | ||
| 0.089 | 0.081 | 0.095 | Nitric-oxide synthase inhibitor | 0.095 0.069 CHEMBL1036 0.089 0.081 CHEMBL54 | CHEMBL1036 | |
| 0.041 | 0.033 | 0.057 | NMDA receptor subunit 3B antagonist | 0.057 0.02 CHEMBL1036 0.041 0.033 CHEMBL54 | CHEMBL1036 | |
| 0.014 | 0.007 | 0.014 | DNA polymerase III polC-type inhibitor | 0.014 0.007 CHEMBL1036 0.014 0.007 CHEMBL54 | ||
| 0.077 | 0.07 | 0.102 | Androgen antagonist | 0.102 0.045 CHEMBL1036 0.077 0.07 CHEMBL54 | CHEMBL1036 | |
| 0.021 | 0.015 | 0.022 | Nociceptin (N/OFQ) receptor agonist | 0.022 0.014 CHEMBL1036 0.021 0.015 CHEMBL54 | CHEMBL1036 | |
| 0.155 | 0.149 | 0.382 | Vasodilator | 0.23 0.082 CHEMBL3527396 0.174 0.127 CHEMBL1036 0.382 0.026 CHEMBL3527395 0.155 0.149 CHEMBL54 | CHEMBL3527395 | |
| 0.117 | 0.113 | 0.231 | Cholinergic | 0.231 0.034 CHEMBL1269 0.117 0.113 CHEMBL54 | CHEMBL1269 | |
| 0.039 | 0.035 | 0.04 | Histamine H3 receptor antagonist | 0.04 0.034 CHEMBL1269 0.039 0.035 CHEMBL54 | CHEMBL1269 | |
| 0.181 | 0.177 | 0.216 | Hypoxia-inducible factor 1 alpha inhibitor | 0.216 0.134 CHEMBL1036 0.181 0.177 CHEMBL54 | CHEMBL1036 | |
| 0.073 | 0.07 | 0.082 | Glycine receptor antagonist | 0.08 0.057 CHEMBL3527396 0.082 0.053 CHEMBL3527395 0.073 0.07 CHEMBL54 | CHEMBL3527395 | |
| 0.053 | 0.051 | 0.063 | Pregnane X receptor antagonist | 0.063 0.024 CHEMBL1036 0.057 0.04 CHEMBL1269 0.053 0.051 CHEMBL54 | CHEMBL1036 | |
| 0.046 | 0.045 | 0.046 | Opioid agonist | 0.046 0.045 CHEMBL54 | ||
| 0.021 | 0.019 | 0.086 | Prostaglandin E2 agonist | 0.086 0.004 CHEMBL1036 0.021 0.019 CHEMBL54 | CHEMBL1036 | |
| 0.252 | 0.251 | 0.267 | Caspase 9 stimulant | 0.267 0.232 CHEMBL3527395 0.252 0.251 CHEMBL54 | CHEMBL3527395 | |
| 0.027 | 0.027 | 0.097 | Prostaglandin agonist | 0.097 0.005 CHEMBL1036 | CHEMBL1036 | |
| 0.058 | 0.057 | 0.081 | 5 Hydroxytryptamine agonist | 0.081 0.041 CHEMBL1269 0.058 0.057 CHEMBL54 | CHEMBL1269 | |
| 0.054 | 0.055 | 0.062 | Potassium channel intermediate-conductance Ca-activated blocker | 0.062 0.038 CHEMBL1269 | CHEMBL1269 | |
| 0.036 | 0.039 | 0.042 | Leukotriene C4 antagonist | 0.042 0.02 CHEMBL1036 | CHEMBL1036 | |
| 0.036 | 0.039 | 0.038 | Thymidine kinase inhibitor | 0.038 0.033 CHEMBL1036 | CHEMBL1036 | |
| 0.026 | 0.03 | 0.043 | Lysophosphatidic acid 2 receptor antagonist | 0.043 0.011 CHEMBL1036 | CHEMBL1036 | |
| 0.103 | 0.107 | 0.137 | Sodium channel blocker | 0.137 0.068 CHEMBL1036 0.114 0.092 CHEMBL1269 | CHEMBL1036 | |
| 0.081 | 0.086 | 0.099 | Glutamate release inhibitor | 0.089 0.063 CHEMBL1036 0.098 0.045 CHEMBL3527395 0.099 0.044 CHEMBL1269 | CHEMBL1269 | |
| 0.058 | 0.063 | 0.08 | Beta 3 adrenoreceptor antagonist | 0.08 0.023 CHEMBL1036 | CHEMBL1036 | |
| 0.089 | 0.097 | 0.131 | Interleukin 1b antagonist | 0.131 0.054 CHEMBL1269 | CHEMBL1269 | |
| 0.163 | 0.174 | 0.264 | 5 Hydroxytryptamine 1E antagonist | 0.264 0.06 CHEMBL1269 | CHEMBL1269 | |
| 0.048 | 0.059 | 0.1 | Glutamate (mGluR) agonist | 0.1 0.023 CHEMBL1269 | CHEMBL1269 | |
| 0.057 | 0.069 | 0.066 | Potassium channel (ATP-sensitive) blocker | 0.066 0.047 CHEMBL1269 | CHEMBL1269 | |
| 0.138 | 0.15 | 0.185 | Insulin sensitizer | 0.185 0.089 CHEMBL1036 | CHEMBL1036 | |
| 0.047 | 0.059 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.045 CHEMBL1269 | CHEMBL1269 | |
| 0.09 | 0.102 | 0.259 | MAO inhibitor | 0.259 0.026 CHEMBL1269 | CHEMBL1269 | |
| 0.099 | 0.113 | 0.133 | Sodium channel (voltage-gated) blocker | 0.133 0.07 CHEMBL1036 0.129 0.074 CHEMBL1269 | CHEMBL1036 | |
| 0.067 | 0.081 | 0.082 | GABA B receptor agonist | 0.082 0.038 CHEMBL1269 | CHEMBL1269 | |
| 0.12 | 0.135 | 0.182 | Interferon gamma antagonist | 0.175 0.054 CHEMBL3527396 0.127 0.118 CHEMBL1036 0.182 0.049 CHEMBL3527395 | CHEMBL3527395 | |
| 0.03 | 0.045 | 0.043 | Dopamine D2 agonist | 0.043 0.032 CHEMBL1036 | CHEMBL1036 | |
| 0.038 | 0.056 | 0.05 | Potassium channel (Inward rectifier) blocker | 0.05 0.034 CHEMBL1269 | CHEMBL1269 | |
| 0.072 | 0.091 | 0.076 | Thioredoxin reductase inhibitor | 0.076 0.075 CHEMBL1269 | CHEMBL1269 | |
| 0.012 | 0.032 | 0.016 | Antibiotic Tetracycline-like | 0.016 0.008 CHEMBL3527395 | CHEMBL3527395 | |
| 0.122 | 0.143 | 0.188 | Interleukin 6 antagonist | 0.188 0.049 CHEMBL1036 0.151 0.088 CHEMBL3527395 | CHEMBL1036 | |
| 0.174 | 0.197 | 0.387 | Transcription factor NF kappa B inhibitor | 0.32 0.086 CHEMBL3527396 0.188 0.181 CHEMBL1036 0.387 0.066 CHEMBL3527395 | CHEMBL3527395 | |
| 0.146 | 0.17 | 0.314 | Interleukin agonist | 0.276 0.061 CHEMBL1036 0.314 0.041 CHEMBL3527395 | CHEMBL3527395 | |
| 0.044 | 0.07 | 0.085 | 5 Hydroxytryptamine 2A agonist | 0.085 0.023 CHEMBL1269 | CHEMBL1269 | |
| 0.079 | 0.106 | 0.097 | Alpha 2d adrenoreceptor antagonist | 0.097 0.054 CHEMBL1269 | CHEMBL1269 | |
| 0.022 | 0.05 | 0.03 | ATP citrate lysase inhibitor | 0.03 0.025 CHEMBL1269 | CHEMBL1269 | |
| 0.091 | 0.12 | 0.14 | Interleukin 8 antagonist | 0.14 0.041 CHEMBL1269 | CHEMBL1269 | |
| 0.037 | 0.066 | 0.071 | H+/K+-transporting ATPase inhibitor | 0.071 0.017 CHEMBL1269 | CHEMBL1269 | |
| 0.038 | 0.068 | 0.056 | Dopamine beta hydroxylase inhibitor | 0.056 0.02 CHEMBL1269 | CHEMBL1269 | |
| 0.111 | 0.142 | 0.131 | Dual specificity phosphatase 3 inhibitor | 0.131 0.114 CHEMBL1269 | CHEMBL1269 | |
| 0.178 | 0.208 | 0.484 | Antithrombotic | 0.356 0.062 CHEMBL3527396 0.217 0.157 CHEMBL1036 0.484 0.031 CHEMBL3527395 | CHEMBL3527395 | |
| 0.018 | 0.051 | 0.059 | Prostaglandin D2 agonist | 0.059 0.005 CHEMBL1036 | CHEMBL1036 | |
| 0.019 | 0.052 | 0.034 | Progesterone antagonist | 0.034 0.026 CHEMBL1269 | CHEMBL1269 | |
| 0.028 | 0.062 | 0.136 | Oleamide hydrolase inhibitor | 0.136 0.005 CHEMBL1269 | CHEMBL1269 | |
| 0.052 | 0.088 | 0.064 | Kallikrein 7 inhibitor | 0.064 0.042 CHEMBL1269 | CHEMBL1269 | |
| 0.081 | 0.119 | 0.294 | Amylase inhibitor | 0.192 0.047 CHEMBL3527396 0.294 0.019 CHEMBL3527395 0.102 0.095 CHEMBL1269 | CHEMBL3527395 | |
| 0.037 | 0.076 | 0.095 | Acetylcholine M2 receptor antagonist | 0.095 0.023 CHEMBL1036 | CHEMBL1036 | |
| 0.094 | 0.134 | 0.119 | Cyclooxygenase inhibitor | 0.119 0.101 CHEMBL1269 | CHEMBL1269 | |
| 0.017 | 0.057 | 0.043 | Sodium/glucose cotransporter inhibitor | 0.043 0.006 CHEMBL3527396 0.043 0.006 CHEMBL3527395 | CHEMBL3527395 | |
| 0.154 | 0.196 | 0.278 | DNA synthesis inhibitor | 0.278 0.052 CHEMBL3527396 0.273 0.054 CHEMBL3527395 0.204 0.118 CHEMBL1269 | CHEMBL3527396 | |
| 0.056 | 0.1 | 0.101 | Macrophage migration inhibitory factor inhibitor | 0.101 0.034 CHEMBL1269 | CHEMBL1269 | |
| 0.014 | 0.06 | 0.045 | Sodium/glucose cotransporter 2 inhibitor | 0.036 0.009 CHEMBL3527396 0.045 0.007 CHEMBL3527395 | CHEMBL3527395 | |
| 0.069 | 0.116 | 0.085 | Thioredoxin inhibitor | 0.081 0.079 CHEMBL3527396 0.085 0.071 CHEMBL3527395 | CHEMBL3527395 | |
| 0.011 | 0.059 | 0.029 | Squalene synthetase inhibitor | 0.029 0.025 CHEMBL3527396 0.027 0.026 CHEMBL3527395 | CHEMBL3527396 | |
| 0.075 | 0.123 | 0.162 | AMP-activated protein kinase stimulant | 0.111 0.057 CHEMBL3527396 0.162 0.021 CHEMBL3527395 | CHEMBL3527395 | |
| 0.109 | 0.159 | 0.133 | Death-associated protein kinase 1 inhibitor | 0.133 0.074 CHEMBL1269 | CHEMBL1269 | |
| 0.025 | 0.075 | 0.048 | Thromboxane A2 antagonist | 0.048 0.038 CHEMBL1269 | CHEMBL1269 | |
| 0.028 | 0.08 | 0.052 | Thromboxane antagonist | 0.052 0.04 CHEMBL1269 | CHEMBL1269 | |
| 0.038 | 0.091 | 0.07 | Sphingosine 1-phosphate receptor 3 antagonist | 0.07 0.025 CHEMBL1269 | CHEMBL1269 | |
| 0.053 | 0.108 | 0.201 | MAO B inhibitor | 0.201 0.024 CHEMBL1269 | CHEMBL1269 | |
| 0.034 | 0.09 | 0.054 | Phosphodiesterase II inhibitor | 0.054 0.04 CHEMBL1036 | CHEMBL1036 | |
| 0.151 | 0.208 | 0.204 | Nitric-oxide synthase stimulant | 0.166 0.163 CHEMBL1036 0.204 0.083 CHEMBL1269 | CHEMBL1269 | |
| 0.079 | 0.136 | 0.137 | Nav1.5 sodium channel blocker | 0.137 0.036 CHEMBL1036 | CHEMBL1036 | |
| 0.063 | 0.12 | 0.153 | Sphingomyelinase inhibitor | 0.153 0.023 CHEMBL1036 | CHEMBL1036 | |
| 0.036 | 0.093 | 0.078 | Purinergic P2 antagonist | 0.078 0.033 CHEMBL1269 | CHEMBL1269 | |
| 0.029 | 0.087 | 0.047 | Phosphodiesterase 2A inhibitor | 0.047 0.039 CHEMBL1036 | CHEMBL1036 | |
| 0.176 | 0.235 | 0.461 | Toll-Like receptor 7 agonist | 0.461 0.04 CHEMBL1036 | CHEMBL1036 | |
| 0.106 | 0.165 | 0.293 | Platelet adhesion inhibitor | 0.259 0.047 CHEMBL3527396 0.188 0.077 CHEMBL1036 0.293 0.036 CHEMBL3527395 | CHEMBL3527395 | |
| 0.052 | 0.114 | 0.18 | Adrenaline agonist | 0.18 0.009 CHEMBL1036 | CHEMBL1036 | |
| 0.088 | 0.151 | 0.134 | Transcription factor STAT6 inhibitor | 0.134 0.039 CHEMBL1269 | CHEMBL1269 | |
| 0.117 | 0.181 | 0.199 | ATPase inhibitor | 0.199 0.038 CHEMBL3527395 | CHEMBL3527395 | |
| 0.099 | 0.165 | 0.217 | NOS3 expression enhancer | 0.168 0.057 CHEMBL3527396 0.217 0.035 CHEMBL3527395 0.134 0.091 CHEMBL1269 | CHEMBL3527395 | |
| 0.043 | 0.109 | 0.065 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.065 0.034 CHEMBL1269 | CHEMBL1269 | |
| 0.004 | 0.071 | 0.036 | Prostaglandin EP4 agonist | 0.036 0.006 CHEMBL1036 | CHEMBL1036 | |
| 0.028 | 0.095 | 0.044 | CC chemokine 4 receptor antagonist | 0.044 0.039 CHEMBL1269 | CHEMBL1269 | |
| 0.065 | 0.133 | 0.095 | D-Ala-D-Ala ligase inhibitor | 0.095 0.035 CHEMBL1269 | CHEMBL1269 | |
| 0.056 | 0.126 | 0.184 | Butyrylcholinesterase inhibitor | 0.184 0.024 CHEMBL1269 | CHEMBL1269 | |
| 0.058 | 0.129 | 0.105 | Mediator release inhibitor | 0.099 0.072 CHEMBL1036 0.105 0.064 CHEMBL3527395 | CHEMBL3527395 | |
| 0.032 | 0.105 | 0.076 | Nicotinic receptor alpha7 subunit antagonist | 0.076 0.018 CHEMBL1269 | CHEMBL1269 | |
| 0.07 | 0.143 | 0.15 | Beta glucuronidase inhibitor | 0.119 0.047 CHEMBL3527396 0.15 0.025 CHEMBL3527395 0.096 0.076 CHEMBL1269 | CHEMBL3527395 | |
| 0.173 | 0.246 | 0.329 | GABA C receptor rho-3 antagonist | 0.329 0.097 CHEMBL1269 | CHEMBL1269 | |
| 0.047 | 0.12 | 0.111 | Acetylcholine nicotinic antagonist | 0.111 0.033 CHEMBL1269 | CHEMBL1269 | |
| 0.169 | 0.245 | 0.455 | Toll-Like receptor agonist | 0.455 0.042 CHEMBL1036 | CHEMBL1036 | |
| 0.103 | 0.179 | 0.141 | Melanin inhibitor | 0.129 0.116 CHEMBL3527396 0.141 0.094 CHEMBL3527395 | CHEMBL3527395 | |
| 0.013 | 0.097 | 0.056 | Glutamate (mGluR2) antagonist | 0.056 0.007 CHEMBL1269 | CHEMBL1269 | |
| 0.052 | 0.137 | 0.074 | Inducible nitric-oxide synthase inhibitor | 0.074 0.073 CHEMBL1036 | CHEMBL1036 | |
| 0.018 | 0.102 | 0.071 | Glutamate (mGluR group II) antagonist | 0.071 0.008 CHEMBL1269 | CHEMBL1269 | |
| 0.043 | 0.129 | 0.061 | Lipocortins synthesis agonist | 0.059 0.038 CHEMBL3527396 0.061 0.034 CHEMBL3527395 | CHEMBL3527395 | |
| 0.097 | 0.184 | 0.305 | Nitric oxide antagonist | 0.243 0.053 CHEMBL3527396 0.305 0.039 CHEMBL3527395 | CHEMBL3527395 | |
| 0.029 | 0.118 | 0.062 | Alpha-mannosidase inhibitor | 0.062 0.025 CHEMBL3527395 | CHEMBL3527395 | |
| 0.04 | 0.129 | 0.06 | Adenine nucleotide translocase inhibitor | 0.058 0.033 CHEMBL3527396 0.06 0.028 CHEMBL3527395 | CHEMBL3527395 | |
| 0.165 | 0.255 | 0.412 | Histamine release inhibitor | 0.412 0.069 CHEMBL3527395 0.223 0.178 CHEMBL1269 | CHEMBL3527395 | |
| 0.097 | 0.187 | 0.183 | DNA methyltransferase I inhibitor | 0.183 0.078 CHEMBL3527395 | CHEMBL3527395 | |
| 0.011 | 0.104 | 0.036 | Protein 30S ribosomal subunit inhibitor | 0.025 0.016 CHEMBL3527396 0.036 0.011 CHEMBL3527395 | CHEMBL3527395 | |
| 0.154 | 0.249 | 0.372 | Immunosuppressant | 0.33 0.097 CHEMBL3527396 0.289 0.122 CHEMBL1036 0.372 0.075 CHEMBL3527395 | CHEMBL3527395 | |
| 0.031 | 0.129 | 0.099 | Neuronal nicotinic receptor antagonist | 0.099 0.025 CHEMBL1269 | CHEMBL1269 | |
| 0.145 | 0.243 | 0.198 | 5 Hydroxytryptamine 3E antagonist | 0.198 0.066 CHEMBL1269 | CHEMBL1269 | |
| 0.084 | 0.184 | 0.178 | Phospholipase A2 inhibitor | 0.178 0.055 CHEMBL1269 | CHEMBL1269 | |
| 0.064 | 0.168 | 0.109 | Multidrug resistance-associated protein 1 inhibitor | 0.109 0.063 CHEMBL3527395 | CHEMBL3527395 | |
| 0.038 | 0.144 | 0.074 | Aryl hydrocarbon receptor antagonist | 0.074 0.033 CHEMBL1269 | CHEMBL1269 | |
| 0.143 | 0.251 | 0.325 | Vasodilator, coronary | 0.207 0.175 CHEMBL3527396 0.325 0.069 CHEMBL3527395 | CHEMBL3527395 | |
| 0.025 | 0.138 | 0.039 | GABA B receptor antagonist | 0.039 0.038 CHEMBL1269 | CHEMBL1269 | |
| 0.093 | 0.209 | 0.212 | DNA methylase inhibitor | 0.212 0.071 CHEMBL3527395 | CHEMBL3527395 | |
| 0.013 | 0.129 | 0.035 | Histone deacetylase 8 inhibitor | 0.035 0.034 CHEMBL1269 | CHEMBL1269 | |
| 0.009 | 0.126 | 0.015 | CC chemokine 10 receptor antagonist | 0.015 0.012 CHEMBL1269 | CHEMBL1269 | |
| 0.025 | 0.143 | 0.081 | TRPA1 antagonist | 0.081 0.025 CHEMBL1269 | CHEMBL1269 | |
| 0.112 | 0.231 | 0.164 | Neurotensin receptor agonist | 0.164 0.072 CHEMBL1269 | CHEMBL1269 | |
| 0.018 | 0.138 | 0.077 | Prostaglandin EP2 antagonist | 0.077 0.028 CHEMBL1036 | CHEMBL1036 | |
| 0.014 | 0.143 | 0.041 | Phosphorylase inhibitor | 0.041 0.036 CHEMBL3527395 | CHEMBL3527395 | |
| 0.043 | 0.172 | 0.068 | Beta 2 adrenoreceptor agonist | 0.068 0.024 CHEMBL1036 | CHEMBL1036 | |
| 0.088 | 0.221 | 0.132 | Adenylate cyclase stimulant | 0.132 0.097 CHEMBL1036 | CHEMBL1036 | |
| 0.017 | 0.152 | 0.047 | Mannosidase inhibitor | 0.041 0.038 CHEMBL1036 0.047 0.029 CHEMBL3527395 | CHEMBL3527395 | |
| 0.075 | 0.217 | 0.178 | Cell wall synthesis inhibitor | 0.178 0.041 CHEMBL3527396 0.113 0.11 CHEMBL1036 0.173 0.045 CHEMBL3527395 0.122 0.097 CHEMBL1269 | CHEMBL3527396 | |
| 0.026 | 0.169 | 0.086 | Catalase inhibitor | 0.086 0.044 CHEMBL1269 | CHEMBL1269 | |
| 0.062 | 0.207 | 0.164 | Cyclooxygenase 3 inhibitor | 0.15 0.048 CHEMBL3527396 0.164 0.037 CHEMBL3527395 | CHEMBL3527395 | |
| 0.016 | 0.166 | 0.057 | 5 Hydroxytryptamine 2 agonist | 0.057 0.03 CHEMBL1269 | CHEMBL1269 | |
| 0.047 | 0.2 | 0.078 | Falcipain inhibitor | 0.078 0.077 CHEMBL1269 | CHEMBL1269 | |
| 0.052 | 0.207 | 0.105 | Transcription factor NF kappa B stimulant | 0.105 0.034 CHEMBL3527396 0.1 0.039 CHEMBL3527395 | CHEMBL3527396 | |
| 0.207 | 0.366 | 0.32 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.32 0.187 CHEMBL1269 | CHEMBL1269 | |
| 0.061 | 0.222 | 0.105 | NADPH oxidase inhibitor | 0.105 0.104 CHEMBL1269 | CHEMBL1269 | |
| 0.064 | 0.227 | 0.176 | Amyloid beta aggregation inhibitor | 0.176 0.091 CHEMBL1269 | CHEMBL1269 | |
| 0.108 | 0.274 | 0.206 | Thyroid hormone beta antagonist | 0.206 0.149 CHEMBL1269 | CHEMBL1269 | |
| 0.019 | 0.186 | 0.046 | Nicotinic receptor alpha4 subunit antagonist | 0.046 0.043 CHEMBL1269 | CHEMBL1269 | |
| 0.035 | 0.202 | 0.082 | Myeloperoxidase inhibitor | 0.082 0.063 CHEMBL1269 | CHEMBL1269 | |
| 0.019 | 0.19 | 0.07 | Prostaglandin-E synthase inhibitor | 0.07 0.048 CHEMBL1269 | CHEMBL1269 | |
| 0.082 | 0.263 | 0.263 | Platelet antagonist | 0.189 0.11 CHEMBL3527396 0.263 0.067 CHEMBL3527395 | CHEMBL3527395 | |
| 0.102 | 0.286 | 0.203 | Thyroid hormone antagonist | 0.203 0.16 CHEMBL1269 | CHEMBL1269 | |
| 0.044 | 0.23 | 0.103 | GABA receptor agonist | 0.103 0.073 CHEMBL1269 | CHEMBL1269 | |
| 0.135 | 0.323 | 0.199 | Caspase 3 stimulant | 0.199 0.171 CHEMBL3527395 | CHEMBL3527395 | |
| 0.041 | 0.233 | 0.1 | UDP-glucose 4-epimerase inhibitor | 0.091 0.072 CHEMBL3527396 0.1 0.061 CHEMBL3527395 | CHEMBL3527395 | |
| 0.074 | 0.273 | 0.143 | DNA repair enzyme inhibitor | 0.107 0.104 CHEMBL3527396 0.143 0.038 CHEMBL3527395 | CHEMBL3527395 | |
| 0.025 | 0.225 | 0.134 | MAO A inhibitor | 0.134 0.046 CHEMBL1269 | CHEMBL1269 | |
| 0.055 | 0.255 | 0.144 | Aldehyde dehydrogenase inhibitor | 0.144 0.051 CHEMBL1269 | CHEMBL1269 | |
| 0.041 | 0.243 | 0.096 | Potassium channel (Voltage-sensitive) activator | 0.096 0.058 CHEMBL1269 | CHEMBL1269 | |
| 0.026 | 0.234 | 0.089 | Potassium channel (Ca-activated) blocker | 0.089 0.013 CHEMBL1269 | CHEMBL1269 | |
| 0.132 | 0.349 | 0.352 | Interleukin 2 agonist | 0.345 0.048 CHEMBL3527396 0.218 0.16 CHEMBL1036 0.352 0.045 CHEMBL3527395 | CHEMBL3527395 | |
| 0.02 | 0.239 | 0.053 | Thromboxane synthase inhibitor | 0.053 0.041 CHEMBL1269 | CHEMBL1269 | |
| 0.109 | 0.33 | 0.22 | Nootropic | 0.22 0.134 CHEMBL1269 | CHEMBL1269 | |
| 0.068 | 0.297 | 0.294 | Hepatoprotectant | 0.286 0.034 CHEMBL3527396 0.294 0.031 CHEMBL3527395 | CHEMBL3527395 | |
| 0.021 | 0.261 | 0.058 | Glucose-6-phosphate translocase inhibitor | 0.049 0.041 CHEMBL3527396 0.058 0.025 CHEMBL3527395 | CHEMBL3527395 | |
| 0.112 | 0.351 | 0.326 | Peptidyltransferase inhibitor | 0.305 0.023 CHEMBL3527396 0.247 0.053 CHEMBL1036 0.326 0.017 CHEMBL3527395 | CHEMBL3527395 | |
| 0.04 | 0.282 | 0.121 | MAP kinase 13 inhibitor | 0.121 0.055 CHEMBL1269 | CHEMBL1269 | |
| 0.068 | 0.311 | 0.301 | Insulin secretagoues | 0.118 0.114 CHEMBL3527396 0.301 0.012 CHEMBL3527395 | CHEMBL3527395 | |
| 0.138 | 0.383 | 0.596 | Cyclophilin D inhibitor | 0.386 0.099 CHEMBL3527396 0.317 0.148 CHEMBL1036 0.596 0.028 CHEMBL3527395 | CHEMBL3527395 | |
| 0.04 | 0.29 | 0.158 | Lipid peroxidase inhibitor | 0.158 0.063 CHEMBL3527395 | CHEMBL3527395 | |
| 0.015 | 0.27 | 0.073 | Protein 50S ribosomal subunit inhibitor | 0.06 0.031 CHEMBL3527396 0.073 0.023 CHEMBL3527395 | CHEMBL3527395 | |
| 0.07 | 0.326 | 0.155 | 3C-like protease (Human coronavirus) inhibitor | 0.155 0.094 CHEMBL1269 | CHEMBL1269 | |
| 0.038 | 0.295 | 0.122 | MAP kinase 12 inhibitor | 0.122 0.068 CHEMBL1269 | CHEMBL1269 | |
| 0.029 | 0.294 | 0.082 | Caspase 7 inhibitor | 0.082 0.056 CHEMBL1269 | CHEMBL1269 | |
| 0.081 | 0.349 | 0.541 | Hypoglycemic | 0.342 0.039 CHEMBL3527396 0.541 0.012 CHEMBL3527395 | CHEMBL3527395 | |
| 0.058 | 0.327 | 0.126 | Hexokinase inhibitor | 0.126 0.11 CHEMBL3527395 | CHEMBL3527395 | |
| 0.03 | 0.302 | 0.221 | Bronchodilator | 0.221 0.015 CHEMBL1036 | CHEMBL1036 | |
| 0.028 | 0.309 | 0.117 | Topoisomerase II inhibitor | 0.094 0.092 CHEMBL3527396 0.117 0.069 CHEMBL3527395 | CHEMBL3527395 | |
| 0.058 | 0.343 | 0.372 | Free radical scavenger | 0.24 0.073 CHEMBL3527396 0.372 0.034 CHEMBL3527395 | CHEMBL3527395 | |
| 0.049 | 0.342 | 0.167 | Interleukin 4 antagonist | 0.167 0.037 CHEMBL1036 | CHEMBL1036 | |
| 0.022 | 0.321 | 0.111 | Alcohol dehydrogenase inhibitor | 0.111 0.042 CHEMBL1269 | CHEMBL1269 | |
| 0.039 | 0.344 | 0.148 | Interleukin 5 antagonist | 0.148 0.012 CHEMBL1036 | CHEMBL1036 | |
| 0.096 | 0.4 | 0.27 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.27 0.088 CHEMBL1269 | CHEMBL1269 | |
| 0.063 | 0.367 | 0.41 | Antioxidant | 0.276 0.072 CHEMBL3527396 0.41 0.033 CHEMBL3527395 | CHEMBL3527395 | |
| 0.09 | 0.395 | 0.129 | CC chemokine 6 receptor antagonist | 0.126 0.086 CHEMBL3527396 0.129 0.074 CHEMBL3527395 | CHEMBL3527395 | |
| 0.027 | 0.333 | 0.1 | Gastric antisecretory | 0.1 0.066 CHEMBL1269 | CHEMBL1269 | |
| 0.047 | 0.357 | 0.171 | Interleukin antagonist | 0.171 0.103 CHEMBL1036 | CHEMBL1036 | |
| 0.058 | 0.377 | 0.333 | Tumour necrosis factor alpha release inhibitor | 0.333 0.043 CHEMBL3527396 0.228 0.087 CHEMBL3527395 | CHEMBL3527396 | |
| 0.086 | 0.407 | 0.272 | Immunomodulator | 0.272 0.099 CHEMBL3527396 0.24 0.123 CHEMBL3527395 | CHEMBL3527396 | |
| 0.005 | 0.327 | 0.039 | Geranyltranstransferase inhibitor | 0.039 0.038 CHEMBL1269 | CHEMBL1269 | |
| 0.034 | 0.36 | 0.087 | Bromodomain-containing protein 2 inhibitor | 0.087 0.062 CHEMBL1269 | CHEMBL1269 | |
| 0.016 | 0.343 | 0.057 | Potassium channel small-conductance Ca-activated blocker | 0.057 0.019 CHEMBL1269 | CHEMBL1269 | |
| 0.038 | 0.366 | 0.164 | Electron transport complex I inhibitor | 0.164 0.015 CHEMBL1036 | CHEMBL1036 | |
| 0.007 | 0.34 | 0.138 | Antineoplastic antibiotic | 0.079 0.058 CHEMBL3527396 0.138 0.034 CHEMBL3527395 | CHEMBL3527395 | |
| 0.024 | 0.37 | 0.086 | ATPase (Vacuolar H+) inhibitor | 0.086 0.065 CHEMBL3527395 | CHEMBL3527395 | |
| 0.026 | 0.373 | 0.075 | Cell adhesion molecule inhibitor | 0.075 0.06 CHEMBL3527395 | CHEMBL3527395 | |
| 0.019 | 0.373 | 0.37 | Topoisomerase I inhibitor | 0.37 0.007 CHEMBL3527396 0.106 0.065 CHEMBL3527395 | CHEMBL3527396 | |
| 0.057 | 0.414 | 0.126 | MAP kinase 3 inhibitor | 0.126 0.118 CHEMBL1269 | CHEMBL1269 | |
| 0.107 | 0.465 | 0.26 | MAP kinase 1 inhibitor | 0.26 0.222 CHEMBL1269 | CHEMBL1269 | |
| 0.017 | 0.384 | 0.057 | Heparanase inhibitor | 0.057 0.028 CHEMBL3527395 | CHEMBL3527395 | |
| 0.054 | 0.424 | 0.17 | DNA damaging | 0.17 0.145 CHEMBL1269 | CHEMBL1269 | |
| 0.013 | 0.395 | 0.055 | Antibiotic Aminoglycoside-like | 0.048 0.014 CHEMBL3527396 0.055 0.01 CHEMBL3527395 | CHEMBL3527395 | |
| 0.077 | 0.459 | 0.525 | Antibacterial | 0.457 0.054 CHEMBL3527396 0.525 0.034 CHEMBL3527395 | CHEMBL3527395 | |
| 0.036 | 0.419 | 0.246 | Immunostimulant | 0.211 0.114 CHEMBL3527396 0.246 0.098 CHEMBL3527395 | CHEMBL3527395 | |
| 0.032 | 0.419 | 0.42 | Angiogenesis stimulant | 0.393 0.023 CHEMBL3527396 0.42 0.019 CHEMBL3527395 | CHEMBL3527395 | |
| 0.092 | 0.495 | 0.382 | Apoptosis agonist | 0.298 0.173 CHEMBL3527396 0.382 0.122 CHEMBL3527395 | CHEMBL3527395 | |
| 0.038 | 0.461 | 0.169 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.169 0.105 CHEMBL1269 | CHEMBL1269 | |
| 0.031 | 0.468 | 0.124 | Cell adhesion inhibitor | 0.124 0.062 CHEMBL3527395 | CHEMBL3527395 | |
| 0.022 | 0.463 | 0.127 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.127 0.109 CHEMBL1269 | CHEMBL1269 | |
| 0.036 | 0.484 | 0.151 | Hemostatic | 0.151 0.067 CHEMBL3527396 0.145 0.074 CHEMBL3527395 | CHEMBL3527396 | |
| 0.007 | 0.494 | 0.22 | Selectin antagonist | 0.172 0.015 CHEMBL3527396 0.22 0.01 CHEMBL3527395 | CHEMBL3527395 | |
| 0.011 | 0.517 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 CHEMBL3527395 | CHEMBL3527395 | |
| 0.088 | 0.692 | 0.378 | Calcium channel L-type activator | 0.378 0.097 CHEMBL1036 | CHEMBL1036 | |
| 0.012 | 0.68 | 0.156 | Thrombolytic | 0.119 0.111 CHEMBL3527396 0.156 0.078 CHEMBL3527395 | CHEMBL3527395 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |